Juxtaglomerular Apparatus Hyperplasia Under Dual Angiotensin Blockade. A Footprint of Adequate RAS Inhibition or a Concern for Renal Fibrosis?

BMC Nephrology - United Kingdom
doi 10.1186/1471-2369-13-21
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prominent Hyperplasia of Renin-Producing Juxtaglomerular Apparatus After Chronic and Complete Blockade of the Renin-Angiotensin System in Adult IgA Nephropathy

CEN Case Reports
Nephrology
2015English

A Blockade of PI3Kγ Signaling Effectively Mitigates Angiotensin II-induced Renal Injury and Fibrosis in a Mouse Model

Scientific Reports
Multidisciplinary
2018English

ACE Inhibition Versus Angiotensin Receptor Blockade: Which Is Better for Renal and Cardiovascular Protection?

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2004English

Erratum To: Dual Blockade of the Renin-Angiotensin System in Chronic Renal Disease: To Do or Not to Do

Clinical and Experimental Nephrology
PhysiologyNephrology
2010English

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Dual Renin-Angiotensin-Aldosterone System Blockade for Diabetic Kidney Disease

Current Diabetes Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

The Relentless Crumbling of the Renin-Angiotensin System (RAS)-blockade Halo

Annals of Translational Medicine
Medicine
2016English

Kidney and Hypertension: Role of the Juxtaglomerular Apparatus.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1997English

Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)

British Journal of Clinical Pharmacology
Pharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy